NeOpuntia® and blood lipid parameters - Scientific substantiation of a health claim related to NeOpuntia® and improvement of blood lipid parameters associated with cardiovascular risk, especially HDL-cholesterol, pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

NeOpuntia®, blood lipid, LDL-cholesterol, HDL-cholesterol, cardiovascular risk
First published in the EFSA Journal
21. August 2008
13. August 2008
Scientific Opinion


No abstract available

Panel members at the time of adoption

Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Andreu Palou, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen.
Panel on Dietetic Products, Nutrition and Allergies
Question Number